×
Close
註冊
登入
主页
医学图书S馆
医学图书D馆
活动
Upcoming Events
Past Events
用户工具
用户指南
语言
English
中文/ Chinese
French
Português
Español
Arabic
Russian
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
分类
Oncology
51594
Global Medical University
5020
Allergy
1783
Anatomy & Morphology
1527
Andrology
414
Anesthesia & Intensive Care
1214
Anesthesiology
5442
Audiology & Speech-Language Pathology
332
Behavioral Sciences
100
Biochemical Research Methods
6818
Biochemistry & Molecular Biology
29335
Biodiversity Conservation
288
Biology
8218
Biophysics
8099
Biotechnology & Applied Microbiology
8197
Cardiac & Cardiovascular Systems
30752
Cardiovascular & Respiratory Systems
1391
Cell & Tissue Engineering
654
Cell Biology
10825
Chemistry, Analytical
4216
Chemistry, Applied
11003
Chemistry, Medicinal
8487
Chemistry, Multidisciplinary
18503
Clinical Immunology & Infectious Disease
442
Clinical Medicine
8751
Clinical Neurology
16238
Clinical Psychology & Psychiatry
1298
Critical Care Medicine
3153
Dentistry, Oral Surgery & Medicine
12959
Dermatology
7601
Developmental Biology
6915
Ecology
645
Education, Scientific Disciplines
1886
Emergency Medicine
3981
Endocrinology, Metabolism & Nutrition
23582
Engineering, Biomedical
3586
Entomology
425
Environmental Medicine & Public Health
4623
Evolutionary Biology
254
Gastroenterology & Hepatology
11883
General & Internal Medicine
6948
Genetics & Heredity
14711
Geriatrics & Gerontology
5022
Gerontology
338
Health Care Sciences & Services
15636
Health Policy & Services
594
Hematology
5456
Immunology
24666
Infectious Diseases
13671
Integrative & Complementary Medicine
2758
Medical Ethics
1146
Medical Informatics
2117
Medical Laboratory Technology
433
Medicine, General & Internal
44233
Medicine, Legal
493
Medicine, Research & Experimental
17436
Microbiology
22778
Mycology
0
Nanoscience & Nanotechnology
5039
Neuroimaging
1293
Neurology
4396
Neurosciences
38942
Nursing
9355
Nutrition & Dietetics
7802
Obstetrics & Gynecology
8102
Ophthalmology
9493
Optics
4025
Orthopedics
11367
Orthopedics, Rehabilitation & Sports Medicine
1729
Otolaryngology
1505
Otorhinolaryngology
4791
Parasitology
1040
Pathology
4888
Pediatrics
21065
Peripheral Vascular Disease
4693
Pharmacology & Pharmacy
33972
Pharmacology/Toxicology
12027
Physiology
8875
Polymer Science
539
Primary Health Care
795
Psychiatry
18891
Psychology
5053
Psychology, Applied
92
Psychology, Biological
335
Psychology, Clinical
785
Psychology, Developmental
222
Psychology, Educational
149
Psychology, Experimental
122
Psychology, Mathematical
0
Psychology, Multidisciplinary
1590
Psychology, Psychoanalysis
41
Psychology, Social
114
Public Health & Health Care Science
2227
Public, Environmental & Occupational Health
26926
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12032
Radiology, Nuclear Medicine & Medical Imaging
7772
Rehabilitation
2967
Remote Sensing
0
Reproductive Biology
2745
Reproductive Medicine
1131
Research/Laboratory Medicine & Medical Technology
3872
Respiratory System
7101
Rheumatology
5751
Social Sciences, Biomedical
1176
Substance Abuse
2676
Surgery
33275
Toxicology
4241
Transplantation
927
Tropical Medicine
314
Urology & Nephrology
12745
Veterinary Sciences
35
Virology
2383
Zoology
0
渠道
FUTURE ONCOLOGY
131
Pathology Society Understanding disease
52
Asian Journal of Oncology
57
Medrxiv - Oncology
833
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
237
BONE MARROW TRANSPLANTATION
758
BREAST CANCER RESEARCH
284
BREAST CANCER RESEARCH AND TREATMENT
715
BRITISH JOURNAL OF CANCER
987
CA-A CANCER JOURNAL FOR CLINICIANS
24
CANCER
432
CANCER AND METASTASIS REVIEWS
195
CANCER CELL INTERNATIONAL
901
CANCER DISCOVERY
176
CANCER MEDICINE
476
CANCER PREVENTION RESEARCH
70
CANCER RESEARCH
297
CANCER RESEARCH AND TREATMENT
20
CANCER SCIENCE
256
CANCERS
4437
CLINICAL CANCER RESEARCH
312
CLINICAL EPIGENETICS
446
CURRENT ONCOLOGY REPORTS
395
CURRENT OPINION IN ONCOLOGY
227
CURRENT TREATMENT OPTIONS IN ONCOLOGY
289
EXPERIMENTAL CELL RESEARCH
774
HEMATOLOGICAL ONCOLOGY
172
INTERNATIONAL JOURNAL OF CANCER
292
JOURNAL FOR IMMUNOTHERAPY OF CANCER
1334
JOURNAL OF CANCER
20
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
990
JOURNAL OF CLINICAL ONCOLOGY
1011
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
783
JOURNAL OF HEMATOLOGY & ONCOLOGY
376
JOURNAL OF NEURO-ONCOLOGY
734
JOURNAL OF PATHOLOGY
39
JOURNAL OF SURGICAL ONCOLOGY
253
LEUKEMIA
756
LIVER CANCER
145
MEDICAL ONCOLOGY
344
MOLECULAR CANCER
467
MOLECULAR CANCER THERAPEUTICS
157
MOLECULAR ONCOLOGY
201
NATURE REVIEWS CANCER
293
NATURE REVIEWS CLINICAL ONCOLOGY
323
NEOPLASIA
259
ONCOGENE
974
ONCOGENESIS
182
ONCOLOGIST
223
ONCOLOGY-NEW YORK
75
ONCOTARGETS AND THERAPY
572
PSYCHO-ONCOLOGY
175
SURGICAL ONCOLOGY-OXFORD
310
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
103
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
166
BMC CANCER
1887
CANCER EPIDEMIOLOGY
406
CANCER GENETICS
31
CANCER MANAGEMENT AND RESEARCH
956
CURRENT ONCOLOGY
816
FRONTIERS IN ONCOLOGY
10107
GENES CHROMOSOMES & CANCER
58
HEREDITARY CANCER IN CLINICAL PRACTICE
88
INFECTIOUS AGENTS AND CANCER
176
INTEGRATIVE CANCER THERAPIES
69
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
630
JOURNAL OF BUON
11
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
294
JOURNAL OF HEPATOCELLULAR CARCINOMA
368
ONCOLOGY
93
ONCOLOGY RESEARCH AND TREATMENT
164
PEDIATRIC BLOOD & CANCER
403
SEMINARS IN ONCOLOGY NURSING
242
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
204
THORACIC CANCER
271
TUMORI J
67
INDIAN JOURNAL OF CANCER
122
JOURNAL OF ONCOLOGY PRACTICE
436
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
910
RADIATION ONCOLOGY
514
WORLD CANCER RESEARCH JOURNAL
129
SOUTH ASIAN JOURNAL OF CANCER
288
BREAST CANCER-BASIC AND CLINICAL RESEARCH
23
CANCER REPORTS
184
CASE REPORTS IN ONCOLOGY
358
CLINICAL CANCER INVESTIGATION JOURNAL
10
CURRENT BREAST CANCER REPORTS
99
CURRENT CANCER THERAPY REVIEWS
23
CURRENT COLORECTAL CANCER REPORTS
29
INDIAN JOURNAL OF SURGICAL ONCOLOGY
533
INTERNATIONAL CANCER CONFERENCE JOURNAL
176
INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY
15
JMIR CANCER
191
JOURNAL OF GASTROINTESTINAL CANCER
375
JOURNAL OF KIDNEY CANCER AND VHL
82
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE
126
RARE TUMORS
23
REHABILITATION ONCOLOGY
104
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
229
MIDDLE EAST JOURNAL OF CANCER
155
NATURE CANCER
414
ONCOLOGY AND THERAPY
110
ONCOLOGY REVIEWS
17
ONKOLOGIJA
39
HORMONES & CANCER / DISCOVER ONCOLOGY
167
FAMILIAL CANCER
143
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
483
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
78
MEDICAL ONCOLOGY
359
PATHOLOGY & ONCOLOGY RESEARCH
21
PSYCHO-ONCOLOGIE
20
STRAHLENTHERAPIE UND ONKOLOGIE
390
SUPPORTIVE CARE IN CANCER
1147
TARGETED ONCOLOGY
222
SCI时时刷
search
全部
推荐
+
HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI
After disease progression on EGFR tyrosine kinase inhibitor (TKI) therapy, patients with EGFR-mutated NSCLC who are then t...
Future Oncology
comment
0
thumb_up
0
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer
Bacillus Calmette-Guérin (BCG) is the standard of care for patients with high-risk non-muscle-invasive bladder cancer (NMI...
Future Oncology
comment
0
thumb_up
0
INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice
Aim: We pooled data from three observational studies (INSIGHT MM, UVEA-IXA and REMIX) to investigate the real-world effect...
Future Oncology
comment
0
thumb_up
0
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors
Mouse double minute 2 homolog (MDM2) is a key negative regulator of the tumor suppressor p53. Blocking the MDM2–p53 intera...
Future Oncology
comment
0
thumb_up
0
Development and validation of algorithms for identifying lines of therapy in multiple myeloma using real-world data
Aim: To validate algorithms based on electronic health data to identify composition of lines of therapy (LOT) in multiple ...
Future Oncology
comment
0
thumb_up
0
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations
Aim: We investigated the effect of shortening time between innovations with the accelerated approval (AA) pathway on patie...
Future Oncology
comment
0
thumb_up
0
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions
Neuregulin 1 (NRG1) fusions are oncogenic drivers that have been detected in non-small-cell lung cancer (NSCLC), pancreati...
Future Oncology
comment
0
thumb_up
0
Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia
Aim: To characterize real-world patients with metastatic hormone-sensitive prostate cancer (mHSPC) and treating physicians...
Future Oncology
comment
0
thumb_up
0
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
What is this summary about? This is a summary of the results of a study called PHAROS. This study looked at combination tr...
Future Oncology
comment
0
thumb_up
0
Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future
Interactions between tumor cells and immune cells in the tumor microenvironment (TME) play a vital role the mechanisms of ...
Future Oncology
comment
0
thumb_up
0
Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA
Aim: Real-world treatment patterns in tenosynovial giant cell tumor (TGCT) patients remain unknown. Pexidartinib is the on...
Future Oncology
comment
0
thumb_up
0
Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas: A plain language summary of SPRINT
What is this summary about? This summary describes a publication about a study called SPRINT. The SPRINT study included 50...
Future Oncology
comment
0
thumb_up
0
Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery
What is this summary about? In this article, we summarize results from the ongoing phase 3 CheckMate 76K clinical study pu...
Future Oncology
comment
0
thumb_up
0
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma
Elranatamab efficacy in the single-arm, registrational MagnetisMM-3 trial (NCT04649359) was compared with that of physicia...
Future Oncology
comment
0
thumb_up
0
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)
Background: The ARROW study demonstrated that once-weekly carfilzomib and dexamethasone (wKd) therapy significantly prolon...
Future Oncology
comment
0
thumb_up
0
Design of a single-center, phase II trial to explore the efficacy and safety of ‘R-ISV-RO’ treatment in advanced tumors
Background: The authors' preclinical study has confirmed that RO adjuvant (composed of TLR 7 agonists [imiquimod/R837] and...
Future Oncology
comment
0
thumb_up
0
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer – a plain language summary
What is this summary about? This PLSP provides a short summary of an original scientific article that presented results fr...
Future Oncology
comment
0
thumb_up
0
Prolonging the lives of African–Americans with metastatic breast cancer by adding palbociclib to an aromatase inhibitor in routine clinical practice: a plain language summary of a real-world database study
This summary is about a study that was published in the medical journal The Oncologist in July 2023. The combination of pa...
Future Oncology
comment
0
thumb_up
0
Treatment outcomes in older patients with metastatic breast cancer receiving palbociclib plus an aromatase inhibitor: a plain language summary
What is this summary about? This summary describes an article published in the medical journal Frontiers in Oncology in Se...
Future Oncology
comment
0
thumb_up
0
Plain language summary of the TRANSFORM study primary analysis results: liso-cell as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen
What is this summary about? People diagnosed with a disease called large B-cell lymphoma (LBCL) may experience return, or ...
Future Oncology
comment
0
thumb_up
0
Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer
The aim of the current research was to investigate the prognostic significance of pretreatment hemoglobin-to-red cell dist...
Future Oncology
comment
0
thumb_up
0
Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer
Aim: To estimate the cost-savings from conversion to biosimilar pegfilgrastim-cbqv that can be reallocated to provide budg...
Future Oncology
comment
0
thumb_up
0
OLIE, ITCC-082: a Phase II trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma
While survival rates for patients with relapsed/refractory osteosarcoma are low, kinase inhibitors have shown efficacy in ...
Future Oncology
comment
0
thumb_up
0
Risk factors for progression or death after first-line platinum-based chemotherapy in real-world patients in the USA with ovarian cancer from 2011 to 2018
Aim: Patient chart data from the USA during the period of January 2011 through October 2018 were used to assess risk facto...
Future Oncology
comment
0
thumb_up
0
Understanding patient factors to increase uptake of cancer screening: a review
Early detection of cancer through organized screening is a central component of population-level strategies to reduce canc...
Future Oncology
comment
0
thumb_up
0
What is the role of real-world data in metastatic renal cell cancer?
K Fife is affiliated with the Urological Malignancies Programme, CRUK Cambridge Centre. She has received advisory, consult...
Future Oncology
comment
0
thumb_up
0
Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma
Aims: Individualized patient profiling is instrumental for personalized management in hepatocellular carcinoma (HCC). This...
Future Oncology
comment
0
thumb_up
0
A robust ferroptosis-related gene signature predicts overall survival in clear cell renal cell carcinoma
Aims: To investigate the prognostic values and potential mechanisms of ferroptosis-related genes in clear cell renal cell ...
Future Oncology
comment
0
thumb_up
0
The future of oncology care requires integration of patient engagement and equity into practice
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial intere...
Future Oncology
comment
0
thumb_up
0
Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy
Aim: To evaluate the prognostic value of the lymph node ratio (LNR) and other clinicopathological factors in patients with...
Future Oncology
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin